Seroprevalence of varicella antibodies in healthcare workers and health sciences students -: Reliability of self-reported history of varicella

被引:26
作者
De Juanes, JR
Gil, A
San-Martín, M
González, A
Esteban, J
de Codes, AG
机构
[1] Rey Juan Carlos Univ, Dept Hlth Sci, Madrid 28922, Spain
[2] Univ Madrid, Hosp 12 Octubre, Prevent Med Serv, Madrid 3, Spain
[3] Aventis Pasteur MSD, Dept Med, Madrid, Spain
关键词
antibodies; healthcare workers; varicella;
D O I
10.1016/j.vaccine.2004.10.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to assess the seroprevalence of varicella antibodies in healthcare workers and students of healthcare professions and to determine the validity of the self-reported varicella history for detecting susceptible subjects. Personnel of a general hospital and students were recruited and a 5 mL blood sample was obtained from all participants. A case report form, including previous self-reported history of varicella, was completed. A total of 91 healthcare workers (mean age, 30.6 years; S.D., 4.0; range, 23-40) and 92 students (mean age, 19.8 years; S.D., 2.5; range, 18-25) were recruited. The prevalence of varicella antibodies was 91.2% in healthcare workers and 92.1% in students. Overall, the sensitivity, specificity, positive and negative predictive values of a self-reported history of varicella were 68.4%, 66.7%, 95.4% and 17.2%, respectively. The preferred approach in these groups at risk of varicella will be to undergo serologic testing before immunization in those with negative or unknown history of varicella. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1434 / 1436
页数:3
相关论文
共 20 条
[1]   Age-specific seroprevalence to varicella-zoster virus:: study in Swiss children and analysis of European data [J].
Aebi, C ;
Fischer, K ;
Gorgievski, M ;
Matter, L ;
Mühlemann, K .
VACCINE, 2001, 19 (23-24) :3097-3103
[2]   Positive predictive value of a health history questionnaire [J].
Burnham, BR ;
Thompson, DF ;
Jackson, WG .
MILITARY MEDICINE, 2002, 167 (08) :639-642
[3]  
Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P5
[4]  
Comm Infect Dis, 2000, PEDIATRICS, V105, P136
[5]   IMMUNITY TO WHOLE VARICELLA-ZOSTER VIRUS-ANTIGEN AND GLYCOPROTEIN-I AND GLYCOPROTEIN-P170 - RELATION TO THE IMMUNIZING REGIMEN OF LIVE ATTENUATED VARICELLA VACCINE [J].
DIAZ, PS ;
SMITH, S ;
HUNTER, E ;
ARVIN, AM .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1245-1252
[6]  
Gil A, 1999, AN ESP PEDIATR, V50, P459
[7]   Varicella and parvovirus B19 immunity among pregnant women in Gijon, Spain [J].
González, AS ;
Guerra, LO ;
de la Guerra, GV ;
Martínez, PDI ;
Sánchez, GS ;
Fernández, AR .
MEDICINA CLINICA, 2002, 119 (05) :171-173
[8]  
GRAY GC, 1990, PEDIATRICS, V86, P867
[9]  
Jerant A F, 1998, J Am Board Fam Pract, V11, P296
[10]   Varicella seroprevalence among Turkish medical students and the validity of disease history [J].
Kanra, G ;
Yalçin, SS ;
Kara, A ;
Yurdakök, K ;
Pehlivanli, T .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (11) :795-796